Xpect Sting Wipes Swab
NDC Package 42961-182-19

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Xpect Sting Wipes (benzocaine 6%) swabs is adults and children over 2 years: apply to affected area not more than 3-4 times daily.Children under 2 years: consult a doctor. This formulation utilizes a swab delivery system. Marketed by Cintas Corporation, this product is identified by NDC 42961-182 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
42961-182-19
Package Description
10 PACKET in 1 BOX / 1 SWAB in 1 PACKET (42961-182-01)
Product Code
42961-182
11-Digit Billing Format
42961018219

Clinical Specifications

Proprietary Name
Xpect Sting Wipes
Non-Proprietary Name
Benzocaine 6%
Substance Name
Benzocaine
Dosage Form
Swab - A small piece of relatively flat absorbent material that contains a drug. A swab may also be attached to one end of a small stick. A swab is typically used for applying medication or for cleansing.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
BENZOCAINE 6 g/1001
Pharmacologic Class
Usage Information
Adults and children over 2 years: apply to affected area not more than 3-4 times daily.Children under 2 years: consult a doctor.

Regulatory & Marketing

Labeler Name
Cintas Corporation
Product Type
Human Otc Drug
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
03-30-2021
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 42961-182-19 identifies a specific commercial package of 10 packet in 1 box / 1 swab in 1 packet (42961-182-01) of Xpect Sting Wipes, a human over the counter drug labeled by Cintas Corporation. This swab is formulated for topical use and contains benzocaine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cintas Corporation on March 30, 2021. The current certification is valid through December 31, 2026.

How is this Cintas Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 42961018219. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
42961-182-19
11-Digit CMS (5-4-2)
42961-0182-19

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.